Health Equity: How Can Pharma Put the “S” in ESG?

Health Equity: How Can Pharma Put the “S” in ESG?

As COVID-19 has unequally affected many racial and ethnic minority groups, the crisis served as a call to action within the public health community, spurring pharma to pursue actionable efforts toward reversing health inequity. Our media analysis found that the top...